Elizabeth Douville, based in Montreal, QC, CA, is currently a President and CEO at IRICoR, bringing experience from previous roles at AmorChem, Genome Canada and Corbin Therapeutics Inc. Elizabeth Douville holds a 2022 - 2023 ICD-Rotman, Directors Education Program @ Institute of Corporate Directors. With a robust skill set that includes Biotechnology, Technology Transfer, Venture Capital, Lifesciences, Mergers and Acquisitions and more, Elizabeth Douville contributes valuable insights to the industry. Elizabeth Douville has 6 emails and 1 mobile phone number on RocketReach.